Anixa Biosciences, Inc. (ANIX) vs Apyx Medical Corporation (APYX)

A side-by-side comparison of Anixa Biosciences, Inc. and Apyx Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIX vs APYX

growth of $100 · dividends reinvested · last 8y
ANIX -22.6% (-3.1%/yr)APYX -59.8% (-10.8%/yr)ANIX compounded faster over this window
0100200Start $1002019202120232025$77$40
ANIX APYX

ANIX vs APYX: by the numbers

  • •APYX is the larger company ($110M vs $104M market cap).
  • •Both run net losses; ANIX's is the smaller (0.00% vs -14.78% net margin).

Metrics side by side

Valuation

MetricANIXAPYX
P/S ratioN/A1.89
P/B ratio7.1710.35

Profitability

MetricANIXAPYX
Gross margin0.00%33.94%
Operating margin0.00%-6.06%
Net margin0.00%-14.78%
ROE-72.02%-80.97%
ROIC-82.35%-6.84%

Growth (annualized)

MetricANIXAPYX
Revenue CAGR (5Y)N/A8.82%
Total return CAGR (5Y)-8.26%-28.10%

Frequently asked

How have ANIX and APYX total returns compared?
Over the past 5 years, ANIX delivered -8.26% and APYX delivered -28.10% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.